Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors

Clinical trial NCT04047862 · COMPLETED

Trial details

NCT number: NCT04047862
Sponsor: BeiGene
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced and Metastatic Solid Tumors

Start date: 2019-08-15
Primary completion: 2024-08-07
Enrollment: 446

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.